US2369065A - Halosteroids and preparation of the same - Google Patents
Halosteroids and preparation of the same Download PDFInfo
- Publication number
- US2369065A US2369065A US409590A US40959041A US2369065A US 2369065 A US2369065 A US 2369065A US 409590 A US409590 A US 409590A US 40959041 A US40959041 A US 40959041A US 2369065 A US2369065 A US 2369065A
- Authority
- US
- United States
- Prior art keywords
- bromine
- solution
- acetic acid
- pregnanol
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 76
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 33
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 32
- 229940074995 bromine Drugs 0.000 description 32
- 229910052794 bromium Inorganic materials 0.000 description 32
- 229960000583 acetic acid Drugs 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
- 239000000460 chlorine Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 19
- 229910052801 chlorine Inorganic materials 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 150000003431 steroids Chemical class 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
- 230000026030 halogenation Effects 0.000 description 10
- 238000005658 halogenation reaction Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 7
- -1 androstane compound Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 229910052736 halogen Inorganic materials 0.000 description 5
- 150000002367 halogens Chemical class 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 230000002140 halogenating effect Effects 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- FZBSQSZEVZDOPL-QUPIPBJSSA-N 1-[(8R,9S,10S,13S,14S,17R)-17-bromo-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone Chemical class Br[C@@]1(CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2CCCC[C@]12C)C(C)=O FZBSQSZEVZDOPL-QUPIPBJSSA-N 0.000 description 1
- RSRDWHPVTMQUGZ-OZIWPBGVSA-N 1-[(8r,9s,10s,13s,14s,17s)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]ethanone Chemical class C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RSRDWHPVTMQUGZ-OZIWPBGVSA-N 0.000 description 1
- GMVAAADTMXYSDE-XFNFOBRPSA-N 2-[(8R,9S,10S,13S,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethenol Chemical compound OC=C[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C GMVAAADTMXYSDE-XFNFOBRPSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- JWMFYGXQPXQEEM-NUNROCCHSA-N 5β-pregnane Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](CC)[C@@]2(C)CC1 JWMFYGXQPXQEEM-NUNROCCHSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000551547 Dione <red algae> Species 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- CPELXLSAUQHCOX-DYCDLGHISA-N deuterium bromide Chemical compound [2H]Br CPELXLSAUQHCOX-DYCDLGHISA-N 0.000 description 1
- 125000000950 dibromo group Chemical group Br* 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- DLLJVQNYBYOKGS-UHFFFAOYSA-N ethoxyethane;pentane Chemical compound CCCCC.CCOCC DLLJVQNYBYOKGS-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000005826 halohydrocarbons Chemical class 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- DBMUNIJZUYVPCQ-XFNFOBRPSA-N pregnan-21-ol Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)CCO)[C@@H]4[C@@H]3CCC21 DBMUNIJZUYVPCQ-XFNFOBRPSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Definitions
- This invention relates to halosteroids and preparation of the same.
- this invention relates to halosteroids which are useful as intermediates for the preparation of androst'ane derivatives.
- androstane and pregnane as used in this specification and in the appended claims are to be understood as comprehending steroids of 19 and 21 carbon atoms respectively, regardless of the particular stereo-chemical configuration in the nucleus.
- the term androstane compound isto be understood to include compounds having the allo-" configuration at C suchv as androsterone, or steroids having the regular configuration at C: such as etio-cholanol-3 (,3) -one-17, as well as ring-unsaturated steroids such as testosterone.
- the halogenation may be controlled to proceed stepwise, with intermediate formation of the 17-halo-20-keto-pregnane compounrL'or the two steps may be effected simultaneously, with direct production of the 17,2i-dihalo keto-pregnanecompoundl v
- the halogenation is best conducted in the presence of a' solvent inert to elementary chlorineor bromine.
- solvents include the liquid lower organic acids, such as acetic acid, propionic acid, etc., halohydrocarbons, such as carbon less of the nature of'the' 'suiistitcents or groupings in rings A, B and C.
- ' have added halogen at the double bond as well as is have u substituted halogen in the grouping attached to ring D.
- a variant oi the above illustration consists first in saturating the ring double bond of the nuclearly unsaturated '20-keto-pregnane compound with halogen, or evenwith hydrogen halide, and
- a -pregneno1-3(,B)-0ne-20 can be brominated in an inert solvent such as car bon tetrachloride, the; 5,6,17,21 tetrabromopregnano1-3(,8)on--20" thus obtained oxidized with chromic acid in acetic acid at room temperature to give 5,6,17,2-1-tetrabromo pregnandione-3-2O and the lattertreated with 2 moles of potassium iodide in boiling alcohol to obtain 17,21 dibromo ,A -pre 'gnenedione 3,20 of formula: i.
- Example 7A The reactions of the l7-bromo-20-keto-pregnane compounds are summarized in the diagram below. 7
- Dehydrohalogenating agents suitable for this punpo'se include the com'bination of an Organic-acid and an inorganic salt or an organic acid, also a tertiary base.
- potassium acetate and acetic acid, sodium acetateacetic acid and also pyridine are 'particularlysatisfac- 'tory dehydrohalogenating agents, but of course other substances may be used such as sodium benzoate in valeric acid, dimethylanili-ne, 'quinoline, triethanolamine.,:etc.
- alkaline agents on a 17- bromo- 'Z'O ketO-pregnane compound leads to molecular rearrangement with the formation of a 17- methyl-etimcholanie acid or a derivative of the carb'oixyl group thereof.
- 17- -bromo-allo-pregnanone-20 is refluxed with methanolic potassium bicarbonate, there is obtained the methyl ester of l'7-methyl-etio-allochola-nic acid, as illustrated below.
- the 17,-bromo- ZO-keto-pregnane compounds maybe further halogenated, thereby forming ;17,21-:dihalo-20- .keto-epregnane compounds;
- dihalo-20-keto-pregnane compound can be obtained.
- 17--chlor o-al1o-pregnanone-20 may be brominatedat 35 C. with formationofl'lchloro-Z'l-bromo-a1lo-pregnanone-20.
- the reaction is best conducted in 'an alcoholic solution using a large excess of strong alkali. Under these conditions there is formed, along with free A -21- pregnenoic acid; a quantity of the ester thereof withthe alcohol used as'a solvent.
- methanolie potassium hydroxide and 17,21-dibromo-allo-pregnanone-20 yield A -2l-allo-pregnenoic acid together with some methyl A -21- allo-pregnenoate.
- Other strong bases may be used instead of potassium hydroxide, such as bases including sodium hydroxide, sodium ethylate,
- A represents a carbon-to-carbon double bond included between C5 and one of C4 and Ca.
- Example 1 A.17-bromo-allo pregnanone-20.To a. solution of 10 g. of a11o-pregnanone-20 in 200 .cc. of
- glacial acetic acid is added 10' drops of concentrated hydrobromic acid and 33.2 cc. of a 1 M. (-1 molar) solution of bro-mine in acetic acid. After standing fifteen minutes thesolution is minutes, then poured into 500 cc. ofv ice-water and filtered. The .rathergummy precipitate is taken up in ether, washed with water and saturated sodium bicarbonate solution and the ether-evaporated. The residue is crystallized from acetone to give 17,21-dibromo-allo-pregnanone-20, M. P. 128-30 C. This gives a depression when mixed with a sample of either 17-bromo-allo-pregnanone-20, M. P. 12 7 C. or allo-pregnanone-ZO, M, P. 132C.
- Example 3 A. 17-bromo-alZo-pregnandZ-3(o) -one-20.To a solution of 17 g. of allo-pregnanol-3(,3) -onee20 in 1 liter of acetic acid is addedat room temperature, dropwise, 54 cc. of a 1 M. solution of bromine in acetic acid. The solution is allowed to stand ten minutes, and then 1 liter of Water is added. The gummy precipitate is collected, taken up in-ether, the ethereal layer washed well with water, and then evaporated. The residue is crystallized from aqueous methanol and from ether-pentane. The product, 17-bromo-allopregnanol-3(,3) -one-20, has M. P. 93-96 C.
- Example 4 I A. 17-bromo-2Jreghanol-3Q3) -one-20 acetate-- A solution of 5 g. of pregnanol-3(o)-one-20 acetate and twodrops of 48% hydrobromic acid in aacaocs tallized from methanol to give compact White crystals of 17 bromo pregnanol e 3(5) -one-20 acetate of M. P. 1524 54 C.
- Example 6 A. 17,21-dibromo-pregnanoi-3(;3) -one-20 acetate.-A solution of g. or pregnanol-MB) -one'- acetate in 150 cc. of glacial acetic acid contalning 2' drops of 48% hydrobromic acid is warmed to 40 C. and then 29 cc. of 1 M. bromine in acetic acid is added dropwise. After the solution has stood for fifteen minutes it is .poured into water and the precipitated solid collected and washed with water. The solid is recrystallized from acetone to-give. white crystals of 17,21- dibromo-pregnanol-Mpi-one-20 acetate of M. P. 190-191 c. p
- Example 7 A. 17,21 -dibromo-pregnanol-3 e) -0ne-20.-T0
- Example 8 17-chloro 1 allo pregflanol-Mfi) -one'-20 ace- 5,6,17,21-tetrabromo-pregnanol-3to) cne-20' ace:
- Example 10 A. 5,6,17,21-tetrabromo pregnanol-Mm-one- 20 acetata-To a solution of 10 g. of A -pregnenol-3(e) -one'20 acetate in 200 cc. of acetic acid is added 28.5 do. of a 1 M. solution ofbromine in acetic acid. Thil a few drops of 43% hydro bromic acid are added, followed by an additional 57' cc. of 1 M. bromine in acetic acid. The Solution is warmed to C. to insure complete" reaction and then the mixture is allowed to stand at room temperature. which has deposited is collected and washed with ether. This is 5,6,17,2l -tetrabromo-pregnanol- 303) -one-20 acetate of M. P. 172 C. dec.
- X and X are members of the class consisting of chlorine and bromine which comprises reacting, under relatively mild conditions, a steroid having at ring D the structure CH2 CH4 l with a member of the class consisting of chlorine and bromine, and further halogenating the steroid having at ring D the structure v thus produced by reacting it above 30 0. with a member of the class consisting of chlorine and bromine; 1 3.
- X is a member of the classconsisting of chlorine and bromine by reacting said steroid above 30 C. with a member of the class con: sisting of chlorine and bromine.
- a ,halosteroid having in ring D the formula where X and X are members of the class consisting of chlorine and bromine.
- a halosteroid of the formula 7 Process for the preparation of a halosteroid of the formula OHzX where the X groups are members of the class con;
- sisting of chlorine and bromine and Y" is a mem ber of the class consisting of and groups hydrolyzable to t.
- Process for preparing a lower fatty acid R ester of a 17,21-dibromo-pregnanol-3-one-20 which comprises reacting a lower fatty acid ester of pregnanol-3-one-20 with at least four'gramatoms of bromine per gram-mole of ketone.
- Process for preparing 17,21-dibromo-pregnano1-(,6) -one-20 acetate which comprises reacting pregnanol-3(;8)-one-20 acetate in acetic acid at 30-100 C. with at least four gram-atoms of bromine per gram-mole of ketone.
- Process for preparing 17,21-dibromo-pregnanol-3(;3 -one-20 which comprises reacting pregnanol'-3(,3)-one-20 with at least four gramatoms of bromine per gram-mole of ketone.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Patented Feb. 6, 1945 UNITED STATES PATENT- o escapes" THE SAME I v Russell: Earl Marker, State College, Pa, and Harry M Crooks, In, Detroit, Mich., assignors to Parke, Davis &' Com corporation of; Michigan Application September 4, 1941, Serial No. 409,590
N" Drawing,
pany, Detroit, Mich*., a
18 Claims. (Cl. 260-397.3)
This invention relates to halosteroids and preparation of the same.
More particularly this invention relates to halosteroids which are useful as intermediates for the preparation of androst'ane derivatives.
The terms androstane and pregnane as used in this specification and in the appended claims are to be understood as comprehending steroids of 19 and 21 carbon atoms respectively, regardless of the particular stereo-chemical configuration in the nucleus. For example, the term androstane compound isto be understood to include compounds having the allo-" configuration at C suchv as androsterone, or steroids having the regular configuration at C: such as etio-cholanol-3 (,3) -one-17, as well as ring-unsaturated steroids such as testosterone.
It has now been found that ZO-ketO-pregnane compounds having in ring. D the structure are surprisingly readily halogenated, that is to say, chlorinated or brominat'ed'. It has been found that this halogenati'on proceeds readily at moderate temperatures and indeed the first'ha'l'ogen atom, which becomes attached to (3-17 can be introduced at room temperature. A second, halogen atom, which becomes attachedto 0-21, can also be introduced at moderate temperatures, best above 30 0'. Much higher temperatures than approximately 100 0. should be avoided because the new halosteroids are somewhat prone to thermal decomposition. it has also been found that the halogenation may be controlled to proceed stepwise, with intermediate formation of the 17-halo-20-keto-pregnane compounrL'or the two steps may be effected simultaneously, with direct production of the 17,2i-dihalo keto-pregnanecompoundl v The halogenation is best conducted in the presence of a' solvent inert to elementary chlorineor bromine. Such solvents include the liquid lower organic acids, such as acetic acid, propionic acid, etc., halohydrocarbons, such as carbon less of the nature of'the' 'suiistitcents or groupings in rings A, B and C.
This does nct imply, however, that rings A, B
' have added halogen at the double bond as well as is have u substituted halogen in the grouping attached to ring D. may be iuustrateu as follows in the case of s pregnen'oi-s-(pw 2(i'acetatez'. ,1 v j orne -o 1 5,. 6, 17, 2l-tetrabronio-pregnanol-3(pique-20 acetate. A variant oi the above illustration consists first in saturating the ring double bond of the nuclearly unsaturated '20-keto-pregnane compound with halogen, or evenwith hydrogen halide, and
then reacting with halogen, for example, as
follows:
. A'x esnee lsww i? e e e.
iii-ma ma;
5-chlorppregnanol-3(B)-one-20 benzoate to-carbon double bonds in rings A, B and C at the same time that halogenation occurs at ring D,
compounds which are halogenated at ring Dian'd'.
which also have a ring A, B or C double bond cannot be directly obtained by halogenation, but 5 must be. obtained by a, combination of reactions. As an illustration, A -pregneno1-3(,B)-0ne-20 can be brominated in an inert solvent such as car bon tetrachloride, the; 5,6,17,21 tetrabromopregnano1-3(,8)on--20" thus obtained oxidized with chromic acid in acetic acid at room temperature to give 5,6,17,2-1-tetrabromo pregnandione-3-2O and the lattertreated with 2 moles of potassium iodide in boiling alcohol to obtain 17,21 dibromo ,A -pre 'gnenedione 3,20 of formula: i.
17,21-dibromc A pregfienedione-iiflfl As nth pfseae'e of nuclear lretone groups in the zo-ketd-pregnanecompound being halo= genated may result'in nuclear halogenation at methylene groups adjacent to the nuclear ketone grouping. Thus, pregnanedione-3,20 on chlo- ,rination yields a mixture of chloro-pregnane- 5 diones containing from one to four chlorine 1 atom at positions 2, ,4, l7 and 21; the order of substitution being in the main 4, 17, 21 and 2 in I the regular and 2, 1'7, 21 and. 4 in the allo series. The same order of halogenation occurs in both series when trihalogenating or dihalogenating. When dihalogenating, for example, the main reaction inlthe-regular series appears to go as illustrated by the following:
I CH3 CI Ia CH3 (|J 0 Pregnanedione-mo lClr-HdAO I t 6 CH3 CH3 -(|J=0 0" yv C1 bon-to-carbon double bond or a ketonegrouping may result in the halogen attacking at these groupings, practically all other groupings remain unaffected by thehalogen; Halogen atom'or ester groupings in rings A; B'or Q remain unaffected, duringthe halogenation. It the halogenation is conducted in a liquid lower organic acid, such as O acetic acid, hydroxyligroups in the nucleus may. be esterified by the catalytic action of the hydro-, halic acid formed as a'by-product during the halogenation. This is illustrated in Example 7A. ,The reactions of the l7-bromo-20-keto-pregnane compounds are summarized in the diagram below. 7
l CH3 CH; (l1 0 (EH: o o w D Reducing agent I-- 4 CH3 CHI" =O CO OHj D i D I OH:
As the above diagram indicates the I'I-bromor ZO- keto pregnane' compounds are' readily reduced to 20-keto-pre'gnane compounds'bynumer need-oat ing diagram.
on, cm i on: CH; lv o=o err-.011 D Br Nit-Eton Amalgamated Zn \Ij Br and H01 The action or dehydrohalogenating agents on 17-bromo-20-keto-pregnane compounds leads to A -unsaturated 20-ke'to-pregnane compounds. Dehydrohalogenating agents suitable for this punpo'se include the com'bination of an Organic-acid and an inorganic salt or an organic acid, also a tertiary base. It has-been found that potassium acetate and acetic acid, sodium acetateacetic acid and also pyridine are 'particularlysatisfac- 'tory dehydrohalogenating agents, but of course other substances may be used such as sodium benzoate in valeric acid, dimethylanili-ne, 'quinoline, triethanolamine.,:etc.
I The action of alkaline agents on a 17- bromo- 'Z'O ketO-pregnane compound leads to molecular rearrangement with the formation of a 17- methyl-etimcholanie acid or a derivative of the carb'oixyl group thereof. For example, if 17- -bromo-allo-pregnanone-20 is refluxed with methanolic potassium bicarbonate, there is obtained the methyl ester of l'7-methyl-etio-allochola-nic acid, as illustrated below.
CH CH3 Methyl 17-methyl-etio-allo-cholanate The new esters of the type of methyl 1'?- methyl-etio-allo-cholanate are very resistant to l;
hydrolysis which mayaccountin tor-the surprising result-that an ester iszobtained iroma reaction-which would ordinarily vhe expected to yield a hydrolyzed product. The reaction mechanism :is :obscure', but it appears that the (nature of the product is "determined ,by the nature of thesolv'en't employed. For example, if 'ethanolic sodium bicarbonate, instead of methanolic bicarbonate, is reacted with i l-promo-alloepregnanol 20, :the nrpro-duct is cholanate. l a 1 As has already been indicated, the 17,-bromo- ZO-keto-pregnane compounds maybe further halogenated, thereby forming ;17,21-:dihalo-20- .keto-epregnane compounds; By using, for the sec.- ond step of halogenation, a halogendifierent from that alreadypresent at 0-17 a mixed '1 ,;21-
dihalo-20-keto-pregnane compound. can be obtained. Thus 17--chlor o-al1o-pregnanone-20may be brominatedat 35 C. with formationofl'lchloro-Z'l-bromo-a1lo-pregnanone-20.
The reactions of the 17,21-dihalo20-ketopregnane compounds are summarized in the following diagram:
OHZX CH; CHaX C=() CH3 o Dehydrohalogenating D I X agent N D l Reducing i agent Strong alkali on; coon CH3 (3 0 8 (I) H D D As the above diagram shows, the reactions of the 17,21-dihalo-20-keto-pregnane compounds are somewhat analogous to the reactions of the 17 halo'-20-keto-pregnane compounds. Thus both classes of compounds are reduced with formation of 20-keto-pregnane compounds, both classes of compounds can be dehydrohalogenated with formation of unsaturated "steroids and-both classes of compounds undergo molecular rearrangement when treated with alkaline agents.
The remarks that have been made as to the type of reagents useful in "reactions with 17-ha1opregnane compounds apply also in the case of 7 can be effected 'by reagents such as zinc and acetic acid, iron and acetic acid, or catalytic hydrogenation in the presence of palladium and pyridine, or more generally by, (a) the combination of a metal and a substance reactive therewith to form nascent hydrogen and (b) catalytic hydrogenation in the presence of palladium and a tertiary amine. It ,hasalso beenfound that the combination of formic acid and a salt thereof is a satisfactory reducing agent for this reaction.
' The:dehydrohalogenation of 17,2l-dihalo 2dketo-pregnane compounds to, 21 -,halo-A -unsaturated ZO-keto-pregnane compounds can be affected by reagents such-as potassium acetate and acetic acid;
The treatment of a 17,21-dihalo-20 keto-preg fnane compound with strong alkali' leads to the formation o-ia zi zl-pregnenoic acid-era derive:-
tive at the'carboxyl' group thereof. The reaction is best conducted in 'an alcoholic solution using a large excess of strong alkali. Under these conditions there is formed, along with free A -21- pregnenoic acid; a quantity of the ester thereof withthe alcohol used as'a solvent. For example, methanolie potassium hydroxide and 17,21-dibromo-allo-pregnanone-20 yield A -2l-allo-pregnenoic acid together with some methyl A -21- allo-pregnenoate. If the reaction is conducted in ethanol or propanol there is obtained, instead of the methyl ester, the ethyl ester or the propyl ester, respectively. Other strong bases may be used instead of potassium hydroxide, such as bases including sodium hydroxide, sodium ethylate,
potassium methylate, etc.
It will be appreciated that this invention comprehends several new classes of steroids, of which an important group consists of compounds of the formula CHa . l X WY Y VXX v and compounds of the formula CH: CH;
and A represents a carbon-to-carbon double bond included between C5 and one of C4 and Ca.
ingi'pointi of1iallo-preghanone-20, M; P. ..132f, by twenty degrees.
" Anal. 03.1011. for CzrHaaOBr: C, 66.2;."I-I,,8.7. Found: C, 65.8; H; 8.8.
B. 17,21.-dibromo-allo-pregna.none-20. To 500 mg. of17-bromo-allo-pregnanone-20 in 35 cc. of glacial acetic acid is added at '35" .C.- 2 drops of 45% aqueous hydrobromic acid and 1.3. cc. of 1.0 M. bromine in acetic acid. After standing for one hour the solution is diluted with water,
filtered, and the solid washed with water. Crystallization from acetone yields a product melt ing at 128-130 C. This is 17,21-dibromo-allopregnanone-20. I 1
Anal. calcd. for C21H32OBr2-3 Found: C, 54.8; H, 7.0.
Example 2 c, 55.0 I-I, 6.6.
, mine. The solution is allowed to stand for thirty Thisinvention may be further illustrated by the following examples.
Example 1 A.17-bromo-allo pregnanone-20.To a. solution of 10 g. of a11o-pregnanone-20 in 200 .cc. of
glacial acetic acid is added 10' drops of concentrated hydrobromic acid and 33.2 cc. of a 1 M. (-1 molar) solution of bro-mine in acetic acid. After standing fifteen minutes thesolution is minutes, then poured into 500 cc. ofv ice-water and filtered. The .rathergummy precipitate is taken up in ether, washed with water and saturated sodium bicarbonate solution and the ether-evaporated. The residue is crystallized from acetone to give 17,21-dibromo-allo-pregnanone-20, M. P. 128-30 C. This gives a depression when mixed with a sample of either 17-bromo-allo-pregnanone-20, M. P. 12 7 C. or allo-pregnanone-ZO, M, P. 132C.
Example 3 A. 17-bromo-alZo-pregnandZ-3(o) -one-20.To a solution of 17 g. of allo-pregnanol-3(,3) -onee20 in 1 liter of acetic acid is addedat room temperature, dropwise, 54 cc. of a 1 M. solution of bromine in acetic acid. The solution is allowed to stand ten minutes, and then 1 liter of Water is added. The gummy precipitate is collected, taken up in-ether, the ethereal layer washed well with water, and then evaporated. The residue is crystallized from aqueous methanol and from ether-pentane. The product, 17-bromo-allopregnanol-3(,3) -one-20, has M. P. 93-96 C.
Anal. calcd. for Gail-11330231: C, 63.5; H, 8.4. Found: C, 63.6; H, 8.1. B. 17,21 dibromo-aZlmpregnanoZ-B(p)-one-20 acetate.To a solution'of 18 g. of 1'7-bromoallo-pregnanol-3(;3)-one-20 in 1 liter of acetic acid is added, at 40 C. one equivalent of a 1 M. solution of bromine in acetic acid. After the bromine has reacted, the solution is diluted with water and the precipitate is taken up in ether.
} The ethereal layer is Washed with water, dilute poured into water, extracted with ether and the ethereal extract washed free of acetic acid with water and dilute sodium carbonate 'soluti'on. Evaporation of the ether gives a residue which is crystallized from ether-methanol and acetone to give crystals, M. P, 127-9 C., of l'l-bromo-allo- 'pregnanone-20. This product depresses the meltsodium carbonate solution, and finally with water. The ether is removed and the residue is crystallized from methanol. The purified 17,21- dibromo-allo-pregnanol-3( 3) -one-20 acetate has M. P. 174 C.
The esterification of the 3-OI-I during the reaction is probably due to the catalytic effect of the hydrogen bromide present."
7 Example 4 I A. 17-bromo-2Jreghanol-3Q3) -one-20 acetate-- A solution of 5 g. of pregnanol-3(o)-one-20 acetate and twodrops of 48% hydrobromic acid in aacaocs tallized from methanol to give compact White crystals of 17 bromo pregnanol e 3(5) -one-20 acetate of M. P. 1524 54 C.
Anal. calcd. for C23H3503BI'Z C, 62.9; H, 8.0.
Found: C, 63.0; H, 7.8.
Example 5 A. 17 bromo pregnanoZ-Mo) -one-20.To a solution of 1.0 g. of pregnanol-3(p).'-one-20 in 50 cc. of glacial acetic acid at=25 C. is added 2 drops at 48% hydrobromic acid. Then 3.13 cc. of a 1 M. solution of bromine in acetic acid is added slowly. After the bromine is all absorbed, the mixture is poured into water and the precipitated solid collected and washed with water. The product is crystallized from ether to give compact white crystals of 17-bromo-pregnanol- 3(3) -ne-20 of M. P. 169171 C.
Anal. calcd. for C21H33O2Br: C, 63.5; H, 8.4. Found: C, 63.1; H, 8.3.
Example 6 A. 17,21-dibromo-pregnanoi-3(;3) -one-20 acetate.-A solution of g. or pregnanol-MB) -one'- acetate in 150 cc. of glacial acetic acid contalning 2' drops of 48% hydrobromic acid is warmed to 40 C. and then 29 cc. of 1 M. bromine in acetic acid is added dropwise. After the solution has stood for fifteen minutes it is .poured into water and the precipitated solid collected and washed with water. The solid is recrystallized from acetone to-give. white crystals of 17,21- dibromo-pregnanol-Mpi-one-20 acetate of M. P. 190-191 c. p
Anal. calcd. for C23H 4O:Br2: G, 53.3; H, 6.6. Found: C, 52.9; Bi, 6.7.
Example 7 A. 17,21 -dibromo-pregnanol-3 e) -0ne-20.-T0
a solution of 10 g. of pregnanol-3(e)-one20 in '300 cc. of glacial acetic acid at 40 C. is added several drops of 48% hydrobromic acid. Then 626 cc. of 1 M. bromine in acetic acid: is added dropwise. After the addition of bromine is completed, the solution is poured into water and the precipitated solid collected and washed with water. The solid is crystallized from ether to give thick white needles of 17,21-dibromo-pregnanol-3(5)-one-20 of M. P. 190-192 C.
Example 8 17-chloro 1 allo pregflanol-Mfi) -one'-20 ace- 5,6,17,21-tetrabromo-pregnanol-3to) cne-20' ace:
tate.- A 1% solution of chlorine iii-chloroform standardized by titration of the available chlorine, for example with potassium iodide and StfilGFl.
To a solution of 1 g. or alio-pregiiasol-smh one-20 acetate in 30cc. of acetic acid at 30 C. is added 10 cc. of an accurately standardized 1% solution of chlorine in chloroform. After the mixture has stood for an hour it is diluted with water and extracted with ether. The ethereal extract is washed with sodium bicarbonate solution and with water and then the extract is evaporated on a steam bath. The residue is 1'7 chlordane-pregnan ies(c) r ced acetate. it may be purified by crystallization from dilute acetone.
Example 10 A. 5,6,17,21-tetrabromo pregnanol-Mm-one- 20 acetata-To a solution of 10 g. of A -pregnenol-3(e) -one'20 acetate in 200 cc. of acetic acid is added 28.5 do. of a 1 M. solution ofbromine in acetic acid. Thil a few drops of 43% hydro bromic acid are added, followed by an additional 57' cc. of 1 M. bromine in acetic acid. The Solution is warmed to C. to insure complete" reaction and then the mixture is allowed to stand at room temperature. which has deposited is collected and washed with ether. This is 5,6,17,2l -tetrabromo-pregnanol- 303) -one-20 acetate of M. P. 172 C. dec.
Anal. calcd. for C23H32O3Br: C, 4028; H, 4.8. Found: C, 40.6; H, 4.8. v u
Bromi-nation or A -pregnenol-3;(fl )=one-20 by the same procedurev gives the same product.
tate.
B. 17,21 -dibromo d pregnenol-Mpl-one-ZO acetate-A solution of'4.36 g. of sodium iodid in 40 100 cc. of alcohol is added to a boiling solution of 10 g. of 5,6,17,21-tetrabromo-pregnanol-3(p)- one-20 acetate in 1500 cc. of ethanol and the mixture boiled for an hour. Then water is added and the mixture is extracted withetner. ethereal extract is washed with dilute sodium bicarbonate solutioriaiid with water and theii'tl'ie ether is removed on the steam bath. The residue is 17,21-dibromo-A pregnenol-3( 3)-one-20 acetate. It may be purified by crystallization from dilute acetone. However, this is unnecessary if the substance is to be used in the next step.
Example 11 A. aainzi-tet biomo Mahatma-i 20 pmpionata-To a solution of 0.60 g. of- A pregnenol ile) -one-20 in 1 0-oc of propionic acid is added 5137 cc.-oi' a 1 solutionof bromine in neno1=-3(e --one--20- propionate is treated with Bromine in the manner described' abdve. A
While this invention has been destined and illustrated with especial reference to certain forms of the invention, and these forms have been explained in terms of a particular theory, it is to be understood that this invention is not limited to these specific forms, nor is its operability in any way affected by the ultimate cor- After several hours the solid rectness of the particular theories herein employed.
What we claim as our invention is: 1. Process for the preparation of a halosteroidn having at ring D the structure CHzX where X is a member of the class consisting of chlorine and bromine which comprises reacting a steroid having at ring D the structure D 1 I with a member of the class consisting of chlorine and bromine.
2. Process for the preparation of a halosteroid.
having at ring D the structure 'cmx' CH3 O where X and X are members of the class consisting of chlorine and bromine which comprises reacting, under relatively mild conditions, a steroid having at ring D the structure CH2 CH4 l with a member of the class consisting of chlorine and bromine, and further halogenating the steroid having at ring D the structure v thus produced by reacting it above 30 0. with a member of the class consisting of chlorine and bromine; 1 3. In a process according to claim 2, the step which comprises reacting, under relatively mild conditions, a steroid having at ring D the structure with amember of the class consisting of chlorine and bromine thereby producing a steroid having atring D the structure t. CH3
c= be 4. Process for the preparation of a'halosteroi'd having at ring D the structure c v where X and X are members of the class con-' sisting of chlorine and bromine which comprises halogenating a steroid having at ring D the structure CH3 2: be
Where X is a member of the classconsisting of chlorine and bromine by reacting said steroid above 30 C. with a member of the class con: sisting of chlorine and bromine.
5. A ,halosteroid having in ring D the formula where X and X are members of the class consisting of chlorine and bromine.
6. A halosteroid of the formula 7. Process for the preparation of a halosteroid of the formula OHzX where the X groups are members of the class con;
sisting of chlorine and bromine and Y" is a mem ber of the class consisting of and groups hydrolyzable to t.
which comprises reacting a steroid of the. formula with a member of the class consisting of chlorine and bromine the quantity of said halogenating agent being at least six gram-atoms per grammole of said steroid. i
8. Process for the preparation of a halosteroid of the formula with a member of the class consisting of chlorine and bromine the quantity of said halogenating agent being at least four gram-atoms per grammole of said steroid.
9. A halosteroid of the formula arms: 7
CH: CH:
where Y represents 10. A lower fatty acid ester of a 17,21-dibromopregnanol-3-one-20.
-11. 17,21-dibromo-pregnanol-3(p)-one-20 acetate melting at approximately ISO-191 C.
12. 17,21 -dibromo pregnanol 3(p) -one 20 melting at approximately 190-192 C.
13. Process for the preparation of ahalosteroid of the formula where X is a member of the class consisting of chlorine and bromine and Y" is a member of the class consisting of H and groups hydrolyzable to I OH which comprises reacting a steroid of the formula CH3 CH3 with at least six gram-atoms per gram-mole of 1 said steroid, of a member of the class consisting of chlorine and bromine, and subjecting the tetra-halosteroid of formula JHiX c=o X thus formed to partial dehalogenation by treating it with a soluble iodide.
- 14. Process for preparing a lower fatty acid R ester of a 17,21-dibromo-pregnanol-3-one-20 which comprises reacting a lower fatty acid ester of pregnanol-3-one-20 with at least four'gramatoms of bromine per gram-mole of ketone.
15. Process for preparing 17,21-dibromo-pregnano1-(,6) -one-20 acetate which comprises reacting pregnanol-3(;8)-one-20 acetate in acetic acid at 30-100 C. with at least four gram-atoms of bromine per gram-mole of ketone.
16. Process for preparing 17,21-dibromo-pregnanol-3(;3 -one-20 which comprises reacting pregnanol'-3(,3)-one-20 with at least four gramatoms of bromine per gram-mole of ketone.
17. A halosteroid having in ring D the formula D I Br 18. 17,21-dibrorno-A -pregnenedione 3,20.
RUSSELL EARL MARKER. HARRY M. CROOKS, JR.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US409590A US2369065A (en) | 1941-09-04 | 1941-09-04 | Halosteroids and preparation of the same |
| US458332A US2359772A (en) | 1941-09-04 | 1942-09-14 | Halosteroids and preparation of the same |
| US460000A US2343311A (en) | 1941-09-04 | 1942-09-28 | Halosteroid and preparation of the same |
| US466674A US2359773A (en) | 1941-09-04 | 1942-11-23 | Unsaturated pregnenoic acids and preparation of same from halosteroids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US409590A US2369065A (en) | 1941-09-04 | 1941-09-04 | Halosteroids and preparation of the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2369065A true US2369065A (en) | 1945-02-06 |
Family
ID=23621157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US409590A Expired - Lifetime US2369065A (en) | 1941-09-04 | 1941-09-04 | Halosteroids and preparation of the same |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2369065A (en) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2441091A (en) * | 1943-01-28 | 1948-05-04 | Hartford Nat Bank & Trust Co | Method of preparing a 7-dehydrosterol |
| US2621180A (en) * | 1950-09-12 | 1952-12-09 | Upjohn Co | 17-bromo steroid adducts |
| US2623044A (en) * | 1950-09-22 | 1952-12-23 | Upjohn Co | 17-bromo 9, 11-oxido steroid adducts |
| US2666068A (en) * | 1951-10-15 | 1954-01-12 | Upjohn Co | Halogenation of steroids |
| US2666067A (en) * | 1951-10-03 | 1954-01-12 | Upjohn Co | Simultaneous oxidation and halogenation of steroids |
| US2667498A (en) * | 1949-09-17 | 1954-01-26 | Glidden Co | Selective dehalogenation of certain halogenated ketones |
| US2681353A (en) * | 1952-03-11 | 1954-06-15 | Sterling Drug Inc | Chlorination of keto-steroids |
| US2684963A (en) * | 1951-09-26 | 1954-07-27 | Abbott Lab | Process for producing 17-bromo steroids |
| US2691013A (en) * | 1952-03-21 | 1954-10-05 | Upjohn Co | Bromosteroids |
| US2708201A (en) * | 1953-10-30 | 1955-05-10 | Searle & Co | 16-haloprogesterones, their 21-hydroxy derivatives and esters thereof |
| US2734899A (en) * | 1956-02-14 | Manufacture of bromevated steroid | ||
| US2739162A (en) * | 1954-01-25 | 1956-03-20 | Merck & Co Inc | Hydrogenation of chloropregnenes |
| US2752341A (en) * | 1952-07-31 | 1956-06-26 | Upjohn Co | Steroid haloketones and process |
| US2778842A (en) * | 1953-07-14 | 1957-01-22 | Upjohn Co | 4, 21-dihalo-17alpha-hydroxypregnane-3, 11, 20-trione |
| US2788353A (en) * | 1952-03-07 | 1957-04-09 | Syntex Sa | 11alpha-hydroxy-3, 20-diketo-pregnenes and allopregnenes unsaturated in ring a and process |
| US2820736A (en) * | 1955-05-16 | 1958-01-21 | Pfizer & Co C | Halogenated steroids |
| US2862011A (en) * | 1953-04-01 | 1958-11-25 | Upjohn Co | Production of 2-bromo-keto-11-oxygenated-4,17-(20)-pregnadiene-21-oic acid esters |
| US2874172A (en) * | 1955-01-26 | 1959-02-17 | Schering Corp | 11-oxygenated 1, 4, 16-pregnatriene-21-ol-3, 20 diones and esters thereof |
| US2925428A (en) * | 1955-08-12 | 1960-02-16 | Syntex Sa | 1-methyl-1, 3, 5, 6, 16 estrapentaenes and a process for making them |
| US2956052A (en) * | 1955-05-12 | 1960-10-11 | Pfizer & Co C | 5alpha, 6beta-dichloro-16, 17alpha-epoxyallopregnanes |
| US2957890A (en) * | 1956-05-28 | 1960-10-25 | Lab Francais Chimiotherapie | Process of preparing pregnene compounds having at least one double bond and one bromine atom in their molecule and products obtained |
| US3041358A (en) * | 1961-06-26 | 1962-06-26 | American Home Prod | Preparation of 17alpha-methyletianic acids |
-
1941
- 1941-09-04 US US409590A patent/US2369065A/en not_active Expired - Lifetime
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2734899A (en) * | 1956-02-14 | Manufacture of bromevated steroid | ||
| US2441091A (en) * | 1943-01-28 | 1948-05-04 | Hartford Nat Bank & Trust Co | Method of preparing a 7-dehydrosterol |
| US2667498A (en) * | 1949-09-17 | 1954-01-26 | Glidden Co | Selective dehalogenation of certain halogenated ketones |
| US2621180A (en) * | 1950-09-12 | 1952-12-09 | Upjohn Co | 17-bromo steroid adducts |
| US2623044A (en) * | 1950-09-22 | 1952-12-23 | Upjohn Co | 17-bromo 9, 11-oxido steroid adducts |
| US2684963A (en) * | 1951-09-26 | 1954-07-27 | Abbott Lab | Process for producing 17-bromo steroids |
| US2666067A (en) * | 1951-10-03 | 1954-01-12 | Upjohn Co | Simultaneous oxidation and halogenation of steroids |
| US2666068A (en) * | 1951-10-15 | 1954-01-12 | Upjohn Co | Halogenation of steroids |
| US2788353A (en) * | 1952-03-07 | 1957-04-09 | Syntex Sa | 11alpha-hydroxy-3, 20-diketo-pregnenes and allopregnenes unsaturated in ring a and process |
| US2681353A (en) * | 1952-03-11 | 1954-06-15 | Sterling Drug Inc | Chlorination of keto-steroids |
| US2691013A (en) * | 1952-03-21 | 1954-10-05 | Upjohn Co | Bromosteroids |
| US2752341A (en) * | 1952-07-31 | 1956-06-26 | Upjohn Co | Steroid haloketones and process |
| US2862011A (en) * | 1953-04-01 | 1958-11-25 | Upjohn Co | Production of 2-bromo-keto-11-oxygenated-4,17-(20)-pregnadiene-21-oic acid esters |
| US2778842A (en) * | 1953-07-14 | 1957-01-22 | Upjohn Co | 4, 21-dihalo-17alpha-hydroxypregnane-3, 11, 20-trione |
| US2708201A (en) * | 1953-10-30 | 1955-05-10 | Searle & Co | 16-haloprogesterones, their 21-hydroxy derivatives and esters thereof |
| US2739162A (en) * | 1954-01-25 | 1956-03-20 | Merck & Co Inc | Hydrogenation of chloropregnenes |
| US2874172A (en) * | 1955-01-26 | 1959-02-17 | Schering Corp | 11-oxygenated 1, 4, 16-pregnatriene-21-ol-3, 20 diones and esters thereof |
| US2956052A (en) * | 1955-05-12 | 1960-10-11 | Pfizer & Co C | 5alpha, 6beta-dichloro-16, 17alpha-epoxyallopregnanes |
| US2820736A (en) * | 1955-05-16 | 1958-01-21 | Pfizer & Co C | Halogenated steroids |
| US2925428A (en) * | 1955-08-12 | 1960-02-16 | Syntex Sa | 1-methyl-1, 3, 5, 6, 16 estrapentaenes and a process for making them |
| US2957890A (en) * | 1956-05-28 | 1960-10-25 | Lab Francais Chimiotherapie | Process of preparing pregnene compounds having at least one double bond and one bromine atom in their molecule and products obtained |
| US3041358A (en) * | 1961-06-26 | 1962-06-26 | American Home Prod | Preparation of 17alpha-methyletianic acids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2369065A (en) | Halosteroids and preparation of the same | |
| US2409798A (en) | Compounds of the cyclopentanopolyhydrophenanthrene series and process of making same | |
| US2351637A (en) | Tetracyclic ketones | |
| US2860158A (en) | Compounds of the perhydrochrysene series and preparation thereof | |
| Lutz et al. | Reduction studies in the morphine series. IX. Hydroxycodeinone | |
| US3555053A (en) | 13beta-alkyl-9beta,10alpha-pregnanes | |
| US2359772A (en) | Halosteroids and preparation of the same | |
| US2437564A (en) | Compounds with cortinlike effect and intermediates thereof and a method of producingthe same | |
| US3077482A (en) | 19-oxygenated steroids and process for their manufacture | |
| US3065228A (en) | Process for the production of delta5-androstene-19-ol and delta5-pregnene-19-ol compounds | |
| US2880233A (en) | Compounds of the perhydrochrysene and related series and preparation thereof | |
| DE1518980C3 (en) | Process for the production of 3-keto-Delta high 4 - or Delta high 1,4 -9 beta, 10 alpha-steroids of the androstane or pregnane series | |
| US3328431A (en) | 6alpha-monofluoromethyl, 6alpha-difluoromethyl and 6alpha-trifluoromethyl progestational hormone derivatives | |
| US3008957A (en) | 6beta, 19-oxido pregnanes | |
| US3231568A (en) | Processes and intermediates for preparing 16alpha-methyl corticoids | |
| US3007922A (en) | Process for the preparation of iminopregnenes novel steroid intermediates prepared thereby and novel 18, 20-oxygenated steroid derivatives | |
| US3036098A (en) | 6-fluoromethyl-17-hydroxy-9, 11-dichloroprogesterones and their 17-esters | |
| US3082223A (en) | 2-methylene-androstanes | |
| US3153061A (en) | 17-substituted 2, 5-pregnadiene derivatives | |
| US3236867A (en) | 2-lower alkyl-androstane-3, 17beta-diols and esters thereof | |
| US3625997A (en) | A 3-oxo-a-nor-b-homo-pregnadienes and a process for their manufacture | |
| US3153646A (en) | Process for the production of 11beta, 12beta-epoxypregnane-3, 20-dione | |
| US2794814A (en) | 4, 16-pregnadiene-3, 11, 20-trione and process | |
| US3148185A (en) | Process for the preparation of 3-hydroxy-6-keto-5beta, 10alpha-steroids | |
| US3484436A (en) | Bicyclo(2.2.2)octane - 1 - -carboxylate esters of delta**4 - pregnene corticoid steroids |